PMID- 30993644 OWN - NLM STAT- MEDLINE DCOM- 20191210 LR - 20200225 IS - 1559-1166 (Electronic) IS - 0895-8696 (Linking) VI - 68 IP - 3 DP - 2019 Jul TI - PACAP Attenuates Optic Nerve Crush-Induced Retinal Ganglion Cell Apoptosis Via Activation of the CREB-Bcl-2 Pathway. PG - 475-484 LID - 10.1007/s12031-019-01309-9 [doi] AB - Retinal ganglion cell (RGC) apoptosis is considered an important pathological hallmark of glaucoma. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a pleiotropic peptide with potent neuroprotective properties. In our previous study, we found that the expression of PACAP and its high-affinity receptor PACAP receptor type 1 (PAC1R) increased markedly after optic nerve crush (ONC), and occurred mainly in the ganglion cell layer of the retina. This suggests that the upregulation of PACAP may play a vital role in inhibiting RGC death after ONC. Therefore, in the present study, we investigate the specific effects and underlying mechanism of PACAP in RGC death after ONC. Vehicle (physiological saline) or PACAP (1 nM to 200 nM) solution was injected into the vitreous body. Seven days later, the retinas were harvested, and the surviving RGCs were retrogradely labeled with Fluoro-Gold (FG; Fluorochrome) at different concentrations of PACAP. Immunofluorescence double staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay were used to observe the effects of PACAP on RGC apoptosis. Our results showed that PACAP treatment inhibited caspase-3-mediated RGC apoptosis, promoted the phosphorylation of cAMP response element binding protein (CREB), up-regulated the expression of B-cell lymphoma 2 (Bcl-2), and ultimately improved RGC survival. These results suggest that PACAP may prevent RGC apoptosis after ONC via activation of CREB-mediated Bcl-2 transcription. The study thus contributes to a basic understanding of the mechanism by which PACAP decreased RGC apoptosis and provides a theoretical basis for future clinical application of PACAP in the treatment of glaucoma. FAU - Ye, Dan AU - Ye D AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 7 Jinsui Road, Guangzhou, 510623, China. FAU - Shi, Yuxun AU - Shi Y AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 7 Jinsui Road, Guangzhou, 510623, China. FAU - Xu, Yue AU - Xu Y AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 7 Jinsui Road, Guangzhou, 510623, China. FAU - Huang, Jingjing AU - Huang J AUID- ORCID: 0000-0002-3009-8681 AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 7 Jinsui Road, Guangzhou, 510623, China. hjjing@mail.sysu.edu.cn. LA - eng PT - Journal Article DEP - 20190416 PL - United States TA - J Mol Neurosci JT - Journal of molecular neuroscience : MN JID - 9002991 RN - 0 (Bcl2 protein, rat) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Neuroprotective Agents) RN - 0 (Pituitary Adenylate Cyclase-Activating Polypeptide) RN - 0 (Proto-Oncogene Proteins c-bcl-2) SB - IM MH - Animals MH - *Apoptosis MH - Cyclic AMP Response Element-Binding Protein/metabolism MH - Male MH - Nerve Crush MH - Neuroprotective Agents/*pharmacology/therapeutic use MH - Optic Atrophy/*drug therapy MH - Pituitary Adenylate Cyclase-Activating Polypeptide/*pharmacology/therapeutic use MH - Proto-Oncogene Proteins c-bcl-2/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Retinal Ganglion Cells/*drug effects/metabolism/pathology MH - Signal Transduction OTO - NOTNLM OT - Apoptosis OT - CREB OT - Optic nerve crush OT - PACAP OT - Retinal ganglion cells EDAT- 2019/04/18 06:00 MHDA- 2019/12/18 06:00 CRDT- 2019/04/18 06:00 PHST- 2019/01/02 00:00 [received] PHST- 2019/03/20 00:00 [accepted] PHST- 2019/04/18 06:00 [pubmed] PHST- 2019/12/18 06:00 [medline] PHST- 2019/04/18 06:00 [entrez] AID - 10.1007/s12031-019-01309-9 [pii] AID - 10.1007/s12031-019-01309-9 [doi] PST - ppublish SO - J Mol Neurosci. 2019 Jul;68(3):475-484. doi: 10.1007/s12031-019-01309-9. Epub 2019 Apr 16.